
arstechnica.com
Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42% - Ars Technica
Markers released top-line results today after previously reporting the trial succeeded.
This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.
Open source